Free Access
Liver transplantation
G. W. McCaughan,
D. J. Koorey,
Corresponding Author
G. W. McCaughan
Associate Professor, A. W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW
A W Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050Search for more papers by this authorD. J. Koorey
Senior Lecturer, A. W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW
Search for more papers by this authorG. W. McCaughan,
D. J. Koorey,
Corresponding Author
G. W. McCaughan
Associate Professor, A. W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW
A W Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050Search for more papers by this authorD. J. Koorey
Senior Lecturer, A. W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW
Search for more papers by this author
References
- 1 R. Strong (Ed.) Australian Liver Transplant Registry, 8th Report. Queensland Liver Transplant Service Publcs.
- 2 Cecka JM, Terasaki PI (Eds.). Worldwide Transplant Center Directory Liver Transplant. Clin Transpl 1995; 667–82.
- 3 McCaughan GW. Selection of patients for liver transplantation. J Gastroenterol Hepatol 1993; 8: 185–94.
- 4
Plevak DJ (Ed.).
Forum on critical care issues in liver transplantation: cardiopulmonary concerns.
Liver Transplant Surg
1996; 2: 306–30.
10.1002/lt.500020411 Google Scholar
- 5 Levy MT, Torzillo P., Bookallil M., Sheil AGR, McCaughan GW. Case report: delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis. J Gastroenterol Hepatol 1996; 11: 734–7.
- 6 Ma Z., Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24: 451–9.
- 7 Mohamed R., Forsey PR, Davies MK, Neuberger JM. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology 1996; 23: 1128–34.
- 8 Shepherd RW, Chin SE, Cleghorn GJ et al. Malnutrition in children with chronic liver disease accepted for liver transplantation: clinical profile and effect on outcome. J Paediatr Child Health 1991; 27: 295.
- 9 Kohern B., Flye MW, Busuttill RW et al. Liver transplantation for hepatoblastoma: the American experience. Am Surg 1991; 213: 188–91.
- 10 Gow PJ, Angus PW, Smallwood RA. Transplantation in patients with paracetamol-induced fulminant hepatic failure. Lancet 1997; 349: 651–2.
- 11 Lee WM, Maddrey WC (Eds.). Acute liver failure and transplantation: a Symposium. Liver Transplant Surg 1995; 1: 176–206.
- 12 O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439–45.
- 13 Berlakovich GA, Steininger R., Herbst F., Barlan M., Mittlbock M., Muhlbacher F. Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation 1994; 58: 560–5.
- 14 Samuel D., Muller R., Alexander G. et al. and the Investigators of the European Concerted Action on Viral Hepatitis. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842–7.
- 15 Angus P., Locarnini S., McCaughan GW, James R., Bowden S. Hepatitis B virus precore mutant infection is associated with severe recurrent disease following liver transplantation. Hepatology 1995; 21: 14–8.
- 16 Levy MH, Chen JJ, McGuinness PH, Koorey D., Sheil AGR, McCaughan GW. Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomes. J Gastroenterol Hepatol 1997; 12: 453–9.
- 17 Busuttil RW, Farmer DG. The surgical treatment of primary hepatobiliary malignancy. Liver Transplant Surg 1996; 2: 114–30.
- 18 Mazzaferro V., Regalia E., Doci R. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 343: 693–9.
- 19 Chui AKK, Ling J., McCaughan GW et al. ABO blood group incompatibility in liver transplantation: A single-centre experience. Aust NZ J Surg 1997; 67: 275–8.
- 20 Takaya S., Brosther O., Iwaki Y. et al. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992; 53: 400–6.
- 21 Kahn D., Gavaler JS, Makowka L., Van Thiel DH. Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci 1993; 38: 1485–8.
- 22 de Ville de Goyet J. Split liver transplantation in Europe -1988 to 1993. Transplantation 1995; 59: 1371–6.
- 23 Strong RW, Lynch SV, Ong TN et al. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322: 1505–7.
- 24 Heffron TG. Living related liver transplantation. Semin Liver Dis 1995; 15: 165–72.
- 25 Padbury RTA, Gunson BK, Dousset B., Hubscher S., Buchels J., Neuberger J. et al. Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Transplantation 1993; 55: 789–94.
- 26 Mirza DF, Gunson BK, Soonawalla Z. et al. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression. Lancet 1997; 346: 701–2.
- 27
Thomson AW.
FK5 06: profile of an important new immunosuppressant.
Transplant Rev
1990; 4: 1–13.
10.1016/S0955-470X(11)80001-7 Google Scholar
- 28 European FK 506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423–8.
- 29 The US Multicentre FK 506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110–5.
- 30 McDiamid SV, Klintmalm GB, Busuttil RW. FK506 conversion for intractable rejection of the liver allograft. Transpl Int 1993; 6: 305–12.
- 31 Sollinger HW et al. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225–32.
- 32 Abraham R., Wiederrecht GJ. Immunopharmacology of Rapamycin. Annu Rev Immunol 1996; 14: 483–510.
- 33 Candinas D., Gunson BK, Nightingale P., Hubscher S., McMaster P., Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995; 346: 1117–21.
- 34 Porayko MK, Kondo M., Steers JL. Liver transplantation: late complications of the biliary tract and their management. Semin Liver Dis 1995; 15: 139–55.
- 35 Feller RB, Waugh RC, Selby WS, Dolan PM, Sheil AGR, McCaughan GW. Biliary strictures after liver transplantation: clinical picture, corrleates and outcomes. J Gastroenterol Hepatol 1996; 11: 21–5.
- 36 McCaughan GW, Herkes R., Powers B., Rickard K., Gallagher ND. Thrombocytopenia post liver transplantation: correlation with pre-operative platelet count, blood transfusion requirements, allograft functions and outcomes. J Hepatol 1992; 16: 16–22.
- 37 Ling R., Mutimer D., Ahmed M. et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24: 711–3.
- 38 Schluger LK, Sheiner PA, Thung SN et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971–6.
- 39 Mazzaferro V., Regalia E., Pulvirenti A. et al. Effect of Interferon and Ribavirin prophylaxis after liver transplantation in HCV-RNA positive patients. Hepatology 1995; 22A: 287.
- 40 Gane EJ, Bernard Ch B., Portmann C. et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815–20.
- 41 Stone MJ, Klintmalm G., Poleter D. et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: A pilot study in 20 patients. Gastroenterology 1993; 104: 196–202.
- 42 Neuberger JM. Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis. J Liver Transplant Surg 1995; 1: 109–15.
- 43
Harrison RF,
Davies MH,
Neuberger JM,
Hubscher SG.
Fibrous and obliterative cholangitis in liver allografts; evidence of recurrent primary sclerosing cholangitis?
Hepatology
1994; 120: 356–61.
10.1002/hep.1840200214 Google Scholar
- 44 Bleday R., Lee E., Jessurun J., Heine J., Wong WD. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36: 908–12.
- 45 Knoop M., Lemmens HP, Bechstein WO et al. Treatment of the Budd-Chiari syndrome with orthotopic liver transplantation and long-term anticoagulation. Clin Transplant 1994; 8: 67–72.
- 46 McCaughan GW, O'Brien E., Sheil AGR. A follow up of 53 adult patients alive beyond 2 years following liver transplantation. J Gastroenterol Hepatol 1993; 8: 569–73.
- 47 Zetterman RK, McCashland TM. Long-term follow-up of the orthotopic liver transplantation patient. Semin Liver Dis 1995; 15: 173–80.
- 48 McCaughan GW, Feller RB. Osteoporosis in chronic liver disease: pathogenesis, risk factors and management. Dig Dis 1994; 12: 223–31.
- 49 Armentis VT, Radomshi JS, Mortiz MJ. Parenthood after liver transplantation. Liver Transplant Surg 1995; (Suppl.): 1: 84–8.
